Effectiveness of new iron polyacrylate preparation in treatment of anemia associated with iron deficiency

Abstract

After the introduction of iron polyacrelate in the main 2 groups there was an increase in Hb 14.5 ± 1 g / l, erythrocytes 4.5±0.3 x1012/l, reticulocytes 9.6%. Similar changes were found in the control group. The iron polyacrelate was found to be as effective as the hemolyph drug. The drug did not change liver activity, i.e. ALT, AST, total bilirubin practically did not change.